Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitroglycerin for COPD Patients
NCT06785337Phase 3Recruiting
- Sponsor
- Beni Suef University
- Start
- Feb 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitroglycerin in chronic obstructive pulmonary disease (COPD), sponsored by Beni Suef University. Started Feb 2025; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06785337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06785337.